Wal-Mart.com USA, LLC
Wal-Mart.com USA, LLC
Wal-Mart.com USA, LLC

Nymox Reports Safety Monitoring Committee Findings for Pivotal Phase 3 NX-1207 Trials

28 July 2010, 7:00 am

HASBROUCK HEIGHTS, N.J. -- Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia .... Read More »

More Topics from "News"


Wal-Mart.com USA, LLC